European Archives - Page 747 of 1116 - European Medical Journal

"We Want to Cover an Entire Therapeutic Spectrum, Helping Patients to Become Owners of their Conditions Alongside Dermatologists"

Alfredo Barón de Juan is Executive Vice President of Global Commercial Operations and Chief Commercial Officer of the Spanish-based pharmaceutical company Almirall. In a recent interview, we discussed a range of topics, such the importance of company values to the success of Almirall and the growth of partnerships and collaboration in the pharma industry.

A Link Between Migraine and Type 2 Diabetes Mellitus

TYPE 2 DIABETES MELLITUS (T2DM) risk is lowered in women who experience migraines, according to the results of a large observational study of French, female patients. With headache disorders…

Overcoming Challenges in Reproductive Health Applications by Deploying More Sensitive and Accurate Molecular Technologies

This review discusses specific challenges associated with traditional non-molecular and older-generation molecular techniques in reproductive health, and…

EMJ Reproductive Health 5 [Suppl 1] 2019

This review discusses specific challenges associated with traditional non-molecular and older-generation molecular techniques in reproductive health, and…

Exercise-Induced Neuron Activity Leads to Sustained Metabolic Benefits

LONG-LASTING metabolic impact of a single exercise session could prove invaluable to patients with diabetes, suggests new research from…

The 5th International Symposium on Collaterals to the Brain (Collaterals 2018)

The 5th International Symposium on Collaterals to the Brain (Collaterals 2018) took place on 6–8th November 2018 in Los Angeles, California, USA.

The European Medical Journal Presents: EMJ Innovations 3.1

The European Medical Journal has published the latest edition of the EMJ Innovations eJournal, which includes a comprehensive review of last year’s MEDICA…

Pharma's year in review: 2018

In this infographic, we have displayed the events and stories that have had a big impact in the world of pharma in 2018. For this, we have focussed on three key areas: M&As, drug approvals, and appointments.

Review of MEDICA 2018

Known as the most prominent event for decision-makers of the international healthcare industry, MEDICA 2018 welcomed around 120,000 visitors and…

EMJ Innovations 3.1 2019

Sit back and relax with this collection of innovative peer-reviewed articles alongside highlights from the 2018 MEDICA Trade Fair.